Case Study

Advanced Lipid Testing—Beyond LDL-P and Apo B

This page was last updated: Oct 28, 2020

Lipoprotein(a) as a Cardiovascular Risk Factor: Current Status

Description: The European Atherosclerosis Society ("EAS") convened a consensus panel for the generation of a consensus document on the evidence base supporting the contention that Lp(a) constitutes a significant cardiovascular risk factor. The NLA officially endorses the statement of the EAS consensus panel. The link above provides the statement of the EAS consensus panel, published October 21, 2010 in the European Heart Journal Early Access.

This page was last updated: Oct 28, 2020

Last Updated: Tuesday, 21-Aug-2012 04:00:00 EDT

Actor John O'Hurley and Dr. Eliot Brinton talk about the seriousness of having high cholesterol and ways to effectively manage the condition.

 

Los Angeles Times Website - June 19, 2012

Last Updated: Thursday, 16-Aug-2012 04:00:00 EDT
An International Masters in Lipidology course debuted in Sydney, Australia in late October 2010. The international faculty included:

Dr. Gerald Watts
Dr. John Chapman, President of the European Atherosclerosis Society
Dr. Richard O'Brien
Last Updated: Sunday, 05-Jul-2015 16:00:00 EDT

The NLA Executive Committee and distinguished guests met in Orlando, Florida on January 21-22, 2017 to discuss the current status of NLA core and non-core programming, trends, products, enhancements to current programming, and future concepts. The Executive Committee reaffirmed the mission and goals of the organization, and developed the attached strategic goals.

The 2017 strategic plan, which was adopted by the NLA Board of Directors on March 7, 2017, is attached for presentation to the membership.